Lev Facher covers the U.S. addiction and overdose crisis. Patients who received higher doses of buprenorphine, a common medication used to alleviate opioid withdrawal and cravings, were less likely to ...

EYEWITNESS NEWS (WBRE/WYOU) — The U.S. Food and Drug Administration (FDA) approved a Buprenorphine treatment option for opioid addiction. According to the FDA, Brixadi is an extended-release injection ...

Adolescents who seek treatment for opioid addiction at an inpatient facility are more likely to be offered horseback riding than given full access to a common, highly effective addiction medication.

Twenty-four percent of US adolescent treatment centers do not use a “lifesaving” medication. An article appeared today in the Journal of the American Medical Association titled “Treatments Used Among ...

Close up of fingers picking up a small pink Suboxone pill. The opioid epidemic is a public health emergency that claims the lives of more than 100 people in the United States every day on average, ...

Please provide your email address to receive an email when new articles are posted on . Approximately 22% of addiction treatment facilities require adolescents be off buprenorphine prior to admission.

While the elimination of the X waiver increased the number of clinicians prescribing buprenorphine, it hasn't yet had a substantial impact on the number of patients taking the drug, according to an ...

It’s easier than ever for doctors to prescribe a key medicine for opioid addiction since the U.S. government lifted an obstacle last year. But despite the looser restrictions and the ongoing overdose ...

April 23, 2012 (Atlanta, GA) — Methadone and buprenorphine are viable analgesic treatment options for patients with chronic pain and comorbid opioid addiction. However, when it comes to safety, ...